Literature DB >> 25643346

Imaging findings and clinical features of intracal lymphoplasmacyte-rich meningioma.

Luo Yongjun1, Liu Xin, Sun Qiu, Zhou Jun-Lin.   

Abstract

PURPOSE: The purpose of this study was to analyze the imaging findings and clinical features of intracal lymphoplasmacyte-rich meningioma. PATIENTS AND METHODS: The clinical, radiographic, and pathological data of 9 patients of lymphoplasmacyte-rich meningioma were analyzed retrospectively.
RESULTS: All cases were solitary; 8 patients with headache, dizziness, and vomiting; 2 patients with vision loss and one with progressive hearing loss; and 4 cases of secondary anemia, 3 of them with secondary hyperplasia of polyclonal immunoglobulin. In the plain CT scan of 6 cases, all masses showed higher density and without clear boundary, and 5 masses accompany obvious peritumoral edema. In plain MRI scan, all of the tumors appeared with irregular shape and unclear boundaries, 8 of the masses with obvious peritumoral edema. Enhanced scan showed all cases were significantly enhanced and the meninges in 7 cases thicken irregularly and extensively. The pathology showed that the tumors were irregularly shaped with grayish red or grayish white cut surfaces. Histological examination showed that the tumors consisted of abundant and diverse cells and different numbers of spindle tumor cells, and meningeal epithelial cells in the background of abundant inflammatory cells could be seen. The 9 cases all had surgery; only 1 case of recurrence in the first year after the operation was noted in the follow-up over 1 to 4 years, and no recurrence could be found after the second surgery.
CONCLUSION: Lymphoplasmacyte-rich meningioma is a seldom-seen subtype meningioma of WHO grade I, often accompanying anemia or polyclonal immunoglobulin hyperplasia, which can recover to normal state after removing the masses. The masses showed higher density and without clear boundary in plain CT scan, and most of the tumors appear with irregular shape, obvious edema, and significant enhancement in the MRI scan. The prognosis is favorable after surgical resection and the recurrence rate is low.

Entities:  

Mesh:

Year:  2015        PMID: 25643346     DOI: 10.1097/SCS.0000000000001193

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  7 in total

Review 1.  Variants of meningiomas: a review of imaging findings and clinical features.

Authors:  Akira Kunimatsu; Natsuko Kunimatsu; Kouhei Kamiya; Masaki Katsura; Harushi Mori; Kuni Ohtomo
Journal:  Jpn J Radiol       Date:  2016-05-02       Impact factor: 2.374

2.  A rare cystic lymphoplasmacyte-rich meningioma: A case report and review of the literature.

Authors:  Muhammad Firdaus; Arwinder S Gill; Rini Andriani; Dian Cahyanti; Maria R Yunti; Ahmad Faried
Journal:  Surg Neurol Int       Date:  2020-11-18

3.  Lymphoplasmacyte-rich meningioma: A rare histologic variant of benign meningioma with atypical bone invasion.

Authors:  Gonçalo Borges de Almeida; Gonçalo Januário
Journal:  Radiol Case Rep       Date:  2022-01-15

4.  Case Report: Creeping Growth in Lymphoplasmacyte-Rich Meningioma-A Radiologic Variant.

Authors:  Jiuhong Li; Xin Zan; Min Feng; Xueyun Deng; Si Zhang; Wenke Liu
Journal:  Front Surg       Date:  2021-12-14

5.  A case of Lymphoplasmacyte-rich meningioma mimicking pachymeningitis.

Authors:  Yue Zhang; Xiang Zhang; Abhijeet Kumar Bhekharee; Zunguo Du; Shuguang Chu
Journal:  BMC Neurol       Date:  2022-07-29       Impact factor: 2.903

6.  Lymphoplasmacyte-rich meningioma with hematologic signs and PD-L1 over-expression.

Authors:  Gabriele Gaggero; Michela Campora; Davide Taietti; Giannamaria Cerruti; Enrico Lo Bue; Monica Truffelli; Marco Ceraudo; Pietro Fiaschi
Journal:  Autops Case Rep       Date:  2022-08-12

Review 7.  Imaging spectrum of meningiomas: a review of uncommon imaging appearances and their histopathological and prognostic significance.

Authors:  Venkatram Krishnan; Mahesh K Mittal; Mukul Sinha; Brij B Thukral
Journal:  Pol J Radiol       Date:  2019-12-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.